Altimmune (ALT) Operating Income (2010 - 2026)
Altimmune (ALT) reported Operating Income of -$24.2 million for Q1 2026, down 11.13% year-over-year from -$27.3 million in Q1 2025, and up 16.09% quarter-over-quarter from -$28.9 million in Q4 2025.
Altimmune (ALT) Operating Income (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Operating Income data on file, last reported at -$24.2 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$24.2 million, down 11.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$96.9 million (up 1.3% YoY), and the FY2025 annual result was -$94.5 million, up 8.42% from the prior year.
- Operating Income improved to -$24.2 million in Q1 2026 per ALT's latest filing, from -$28.9 million in the prior quarter.
- Over five years, Operating Income peaked at -$18.0 million in Q2 2023 and troughed at -$33.6 million in Q4 2023.
- A 5-year average of -$23.9 million and a median of -$23.1 million in 2022 frame the typical range for Operating Income.
- On a YoY basis, Operating Income climbed as much as 26.04% in 2024 and fell as far as 48.53% in 2024.
- A 5-year view of Operating Income shows it stood at -$23.1 million in 2022, then slumped by 45.59% to -$33.6 million in 2023, then advanced by 26.04% to -$24.9 million in 2024, then slipped by 16.19% to -$28.9 million in 2025, then gained by 16.09% to -$24.2 million in 2026.
- Business Quant data shows ALT's Operating Income at -$24.2 million in Q1 2026, -$28.9 million in Q4 2025, and -$20.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | -24.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.24 Mn |
| Dec 31, 2025 | -28.89 Mn |
| Sep 30, 2025 | -20.86 Mn |
| Jun 30, 2025 | -22.92 Mn |
| Mar 31, 2025 | -21.82 Mn |
| Dec 31, 2024 | -24.87 Mn |
| Sep 30, 2024 | -24.77 Mn |
| Jun 30, 2024 | -26.75 Mn |
| Mar 31, 2024 | -26.79 Mn |
| Dec 31, 2023 | -33.62 Mn |
| Sep 30, 2023 | -22.54 Mn |
| Jun 30, 2023 | -18.01 Mn |
| Mar 31, 2023 | -21.76 Mn |
| Dec 31, 2022 | -23.09 Mn |
| Sep 30, 2022 | -24.75 Mn |
| Jun 30, 2022 | -20.40 Mn |
| Mar 31, 2022 | -19.50 Mn |
| Dec 31, 2021 | -23.99 Mn |
| Sep 30, 2021 | -33.20 Mn |
| Jun 30, 2021 | -24.86 Mn |